4-Chloro-2-(2,6-dioxopiperidin-3-yl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione, 97%, 250mg

Monocarbinol terminated polydimethylsiloxane, asymmetric, 80-90cSt, 97%, 100g

methyl 2-{[(2-ethoxy-4-formylphenoxy)acetyl]amino}benzoate, 100mg

7-Fluoro-3-hydroxy-3-phenylindolin-2-one, 98%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)amino)propanoic acid, 97%, 1g

Benzyl cyclopropylcarbamate, 97%, 1g

1-(4-tert-Butyl-phenyl)-ethylamine, 90.0%, 25g

(S)-2,2-Dimethylchroman-4-amine hydrochloride, 98%, 1g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-methoxyphenyl)propanoic acid, 98%, 1g

6-Hydroxy-2-naphthonitrile, 97.0%, 25g

4-(Trifluoromethyl)benzylamine>98.0%(T)5g

3-Bromo-1-chloro-4-fluorobenzene, 98.0%, 500g

2,4,6-Tri-tert-butylpyrimidine>98.0%(GC)1g